Concepedia

Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy

Dawn L. Hershman, Louis H. Weimer, Antai Wang, Grace Kranwinkel, Lois Brafman, Déborah Fuentes, Danielle Awad, Katherine D. Crew

Breast Cancer Research and Treatment · 2010 · 268 citations · 32 references

DOI

Concepts

References

32

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

David Cella, David S. Tulsky, Geoffrey V. Gray et al. · Journal of Clinical Oncology · 1993 · 5.9K citations

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

I. Craig Henderson, Donald A. Berry, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 1.3K citations

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

Joseph A. Sparano, Molin Wang, Silvana Martino et al. · New England Journal of Medicine · 2008 · 1K citations · Full text

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20

Tjeerd J. Postma, Neil K. Aaronson, Jan J. Heimans et al. · European Journal of Cancer · 2005 · 559 citations · Full text

, , +11

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

Stephen E. Jones, Michael A. Savin, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2006 · 537 citations · Full text